Developing story — details emerging. Check the source link for the latest updates.
Source: [Investing.com](https://www.investing.com/news/company-news/haisco-licenses-two-drug-candidates-to-nuvectis-for-40m-upfront-93CH-4755809)
Gains have been pared back at the space and AI company following an initial surge after its record-breaking IPO.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.